Comparison Between Macrophage Activation and Enhancement of Nonspecific Resistance to Tumors by Mycobacterial Immunoadjuvants

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1975 Oct 1

PMID 812088

Citations 38

Authors

D Juy

L CHEDID

Affiliations

Soon will be listed here.

Abstract

It has repeatedly been observed that various bacterial preparations could increase the host's resistance to tumors. It has also been shown that after nonspecific activation by BCG (bacillus Calmette-Guérin), peritoneal macrophages could inhibit in vitro the growth of neoplastic target cells. In the present study a fraction extracted from Myobacterium smegmatis and referred to as interphase material was tested in view of measuring its ability to activate macrophages in vitro and in vivo. This preparation was previously shown to protect mice against a syngeneic leukemia and to increase the immune response of the guinea pig. Other water-soluble adjuvants devoid of demonstrable antitumor activity in vivo were also assayed. The results argue in favor of a correlation between adjuvant activity and the capacity of activating macrophages. Moreover, interphase material administered in vivo consistently induced stronger and more persistent stimulations of macrophages than the other preparations assayed.

Citing Articles

Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium.

Archambault D, Morin G Can Vet J. 1988; 29(1):51-8.

PMID: 17422948 PMC: 1680745.

Kupffer cells and pit cells are not effective in the defense against experimentally induced colon carcinoma metastasis in rat liver.

Griffini P, Smorenburg S, Vogels I, Tigchelaar W, Van Noorden C Clin Exp Metastasis. 1996; 14(4):367-80.

PMID: 8878411 DOI: 10.1007/BF00123396.

Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.

Humphres R, Henika P, FERRARESI R, Krahenbuhl J Infect Immun. 1980; 30(2):462-6.

PMID: 7439991 PMC: 551335. DOI: 10.1128/iai.30.2.462-466.1980.

Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Pabst M, JOHNSTON Jr R J Exp Med. 1980; 151(1):101-14.

PMID: 7350246 PMC: 2185752. DOI: 10.1084/jem.151.1.101.

Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.

Krahenbuhl J, Sharma S, FERRARESI R, Remington J Infect Immun. 1981; 31(2):716-22.

PMID: 7216470 PMC: 351369. DOI: 10.1128/iai.31.2.716-722.1981.

References

Adam A, Ciorbaru R, PETIT J, Lederer E . Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis. Proc Natl Acad Sci U S A. 1972; 69(4):851-4. PMC: 426579. DOI: 10.1073/pnas.69.4.851. View

Kaplan A, Morahan P, Regelson W . Induction of macrophage-mediated tumor-cell cytotoxicity by pyran copolymer. J Natl Cancer Inst. 1974; 52(6):1919-23. DOI: 10.1093/jnci/52.6.1919. View

Cleveland R, Meltzer M, Zbar B . Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG. J Natl Cancer Inst. 1974; 52(6):1887-95. DOI: 10.1093/jnci/52.6.1887. View

GILLETTE R, SWANSON M . Kinetic studies of macrophages. V. Effect of antigen and adjuvant stimulation. J Reticuloendothel Soc. 1974; 15(1):31-40. View

CHEDID L, LAMENSANS A, Parant F, Parant M, Adam A, PETIT J . Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice. Cancer Res. 1973; 33(9):2187-95. View

Adam A, Ciorbaru R, PETIT J, Lederer E, CHEDID L, LAMENSANS A . Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca. Infect Immun. 1973; 7(6):855-61. PMC: 422774. DOI: 10.1128/iai.7.6.855-861.1973. View

Hibbs Jr J, Lambert Jr L, Remington J . Adjuvant induced resistance to tumor development in mice. Proc Soc Exp Biol Med. 1972; 139(3):1053-6. DOI: 10.3181/00379727-139-36296. View

Bennett B . Specific suppression of tumor growth by isolated peritoneal macrophages from immunized mice. J Immunol. 1965; 95(4):656-64. View

Evans R, Alexander P . Cooperation of immune lymphoid cells with macrophages in tumour immunity. Nature. 1970; 228(5272):620-2. DOI: 10.1038/228620a0. View

10.

Old L, CLARKE D, Benacerraf B . Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse. Nature. 1959; 184(Suppl 5):291-2. DOI: 10.1038/184291a0. View

11.

BIOZZI G, STIFFEL C, HALPERN B, Mouton D . [Effect of inoculation with Calmette-Guerin bacillus on the development of Ehrlich ascites tumor in the mouse]. C R Seances Soc Biol Fil. 1959; 153:987-9. View

12.

Weiss D, BONHAG R, DeOME K . Protective activity of fractions of tubercle bacilli against isologous tumours in mice. Nature. 1961; 190:889-91. DOI: 10.1038/190889a0. View

13.

Hibbs Jr J, Lambert Jr L, Remington J . Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol. 1972; 235(54):48-50. DOI: 10.1038/newbio235048a0. View

14.

Alexander P, Evans R . Endotoxin and double stranded RNA render macrophages cytotoxic. Nat New Biol. 1971; 232(29):76-8. DOI: 10.1038/newbio232076a0. View

15.

Modolell M, Luckenbach G, Parant M, MUNDER P . The adjuvant activity of a mycobacterial water soluble adjuvant (WSA) in vitro. I. The requirement of macrophages. J Immunol. 1974; 113(1):395-403. View

16.

MATHE G . Active immunotherapy. Adv Cancer Res. 1971; 14:1-36. DOI: 10.1016/s0065-230x(08)60517-5. View

17.

Keller R . Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J Exp Med. 1973; 138(3):625-44. PMC: 2139416. DOI: 10.1084/jem.138.3.625. View

18.

Hibbs Jr J . Macrophage nonimmunologic recognition: target cell factors related to contact inhibition. Science. 1973; 180(4088):868-70. DOI: 10.1126/science.180.4088.868. View

19.

Zbar B, Bernstein I, Rapp H . Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin. J Natl Cancer Inst. 1971; 46(4):831-9. View

20.

Juy D, Bona C, CHEDID L . [Antitumoral effect of peritoneal macrophages activated by a water-soluble adjuvant of mycobacterial origin]. C R Acad Hebd Seances Acad Sci D. 1974; 278(22):2859-62. View